BlossomHill Therapeutics, Inc. (BLSM)
| Market Cap | 482.17M+3.6% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 29.08M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,892.072 |
| Open | 16.52 |
| Previous Close | 16.61 |
| Day's Range | 16.18 - 16.63 |
| 52-Week Range | 15.25 - 27.99 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 38.33(+131.18%) |
| Earnings Date | n/a |
BlossomHill Therapeutics, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
About BLSM
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$BLSM stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in BLSM holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BLSM's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BLSM Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BLSM patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BLSM from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in BLSM
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.01M |
| VXFVanguard Extended Market ETF | $383.20K |
| VTWOVanguard Russell 2000 ETF | $173.76K |
| VTWGVanguard Russell 2000 Growth ETF | $17.40K |
| VTWVVanguard Russell 2000 Value ETF | $6.41K |
| VTHRVanguard Russell 3000 ETF | $2.49K |
Estimated from each fund’s disclosed top holdings × AUM
BLSM Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BLSM’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score